interest for enhancing drug delivery to tumors and to the brain, via stable or inertial cavitation and sonoporation mechanisms. [3][4][5][6][7] MB-enhanced drug delivery can be realized via direct and indirect approaches. In the direct approach, drug molecules are incorporated into the MB shell, and upon US-mediated MB destruction, they are either locally released from the MB shell, or locally deposited in target tissues in shell fragments, from which they can then gradually be released. [8,9] In case of indirect drug delivery, drugs or drug-loaded nanocarrier materials are coinjected with MB. [10] By temporarily perforating endothelial linings via MB cavitation, coinjected drugs can be delivered more efficiently across the vascular wall, for example in tumors or in the brain, leading to enhanced extravasation, penetration and accumulation at pathological sites. [7,11] MB can be stabilized by a shell of lipids or polymers. Polymeric MB are characterized by a much thicker shell than lipid-based MB. [12,13] This makes polymeric MB more Microbubbles (MB) are routinely used as contrast agents for ultrasound (US) imaging. In recent years, MB have also attracted interest as drug delivery systems. Soft-shelled lipidic MB tend to be more advantageous for US imaging, while hard-shelled polymeric MB appear to be more suitable for drug delivery purposes because of their thicker shell and the resulting higher drug loading capacity. The physicochemical composition of the shell of polymeric MB, however, remains largely unknown. This study sets out to evaluate the molecular weight and polydispersity of the building blocks constituting the shell of poly(butyl cyanoacrylate) (PBCA) MB. Several different PBCA MB were synthesized, varying preparation parameters such as pH, surfactant, stirring speed, and stirring time. Using gel permeation chromatography, it is found that the number average molecular weight (M n ) of the polymer chains in the shell of PBCA MB is 4 kDa, and that >99% of the polymer chains are below 40 kDa. This demonstrates that virtually all polymeric building blocks in the shell of PBCA MB have a size which allows for renal excretion, thereby supporting their use for drug delivery applications.